ABIONYX Pharma SA (ABNX.PA)

EUR 1.25

(2.46%)

Annual Balance Sheets

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 14.71 Million 15.82 Million 21.83 Million 10.28 Million 10.24 Million 13.13 Million
Total Current Assets 6.88 Million 7.57 Million 13.01 Million 10.03 Million 10.12 Million 12.78 Million
Cash And Short Term Investments 4.1 Million 4.04 Million 7.93 Million 9.15 Million 8.33 Million 11.45 Million
Cash and Cash Equivalents 4.1 Million 4.04 Million 7.93 Million 9.15 Million 8.33 Million 11.45 Million
Short Term Investments - -41 Thousand -31 Thousand - - 9.49 Million
Net Receivables 2.49 Million 3.05 Million 4.61 Million 841 Thousand 1.77 Million 1.29 Million
Inventory 221 Thousand 147 Thousand 177 Thousand 38 Thousand - -1.29 Million
Other Current Assets 66 Thousand 325.99 Thousand 280 Thousand -1000.00 24 Thousand 1.32 Million
Total Non-Current Assets 7.82 Million 8.25 Million 8.82 Million 255 Thousand 124 Thousand 351 Thousand
Net PPE 2.21 Million 2.55 Million 3.06 Million 115 Thousand 93 Thousand 23 Thousand
Good Will And Intangible Assets 5.45 Million 5.45 Million 5.45 Million 45 Thousand - 213 Thousand
Good Will 5.37 Million 5.37 Million 5.37 Million - - -
Intangible Assets 80 Thousand 75 Thousand 78 Thousand 45 Thousand - 213 Thousand
Long-Term Investments 133 Thousand 124 Thousand 114 Thousand - - 15 Thousand
Tax Assets 80 Thousand -124 Thousand -114 Thousand - - -15 Thousand
Other Non Current Assets -61 Thousand 240 Thousand 300 Thousand 95 Thousand 31 Thousand 115 Thousand
Other Assets - - - 1000.00 - -
Total Liabilities 6.91 Million 8.65 Million 11.15 Million 3.65 Million 3.58 Million 9.29 Million
Total Current Liabilities 3.92 Million 5.09 Million 6.74 Million 3.59 Million 3.46 Million 8.51 Million
Account Payables 1.43 Million 1.85 Million 2.7 Million 2.41 Million 1.25 Million 2.11 Million
Tax Payables 225 Thousand 171 Thousand 401 Thousand 17 Thousand 59 Thousand 11 Thousand
Short Term Debt 815 Thousand 870 Thousand 1.05 Million 24 Thousand 1.16 Million 5 Million
Deferred Revenue 640 Thousand - 1.77 Million 948 Thousand 990 Thousand 11 Thousand
Other Current Liabilities 1.03 Million 2.37 Million 1.21 Million 215 Thousand 59 Thousand 1.38 Million
Total Non Current Liabilities 2.98 Million 3.56 Million 4.4 Million 61 Thousand 117 Thousand 787 Thousand
Long-Term Debt 1.1 Million 3.14 Million 3.9 Million - 23 Thousand 500 Thousand
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.88 Million 417 Thousand 504 Thousand 61 Thousand 94 Thousand 287 Thousand
Other Liabilities - - - - - -
Total Equity 7.79 Million 7.16 Million 10.67 Million 6.62 Million 6.66 Million 3.83 Million
Stock Holders Equity 7.79 Million 7.16 Million 10.67 Million 6.62 Million 6.66 Million 3.83 Million
Common Stock 1.62 Million 1.41 Million 1.39 Million 1.23 Million 1.09 Million 947 Thousand
Retained Earnings -3.51 Million -4.2 Million -5.82 Million -1.88 Million 1.84 Million -6.3 Million
Accumulated other comprehensive income -6.08 Million -2.61 Million -169.73 Million 11.8 Million 11.76 Million 11.65 Million
Common Stock Equity 7.79 Million 7.16 Million 10.67 Million 6.62 Million 6.66 Million 3.83 Million
Capital Lease Obligation 1.47 Million 2.1 Million 2.65 Million 24 Thousand 83 Thousand -
Total Investments 133 Thousand 83 Thousand 83 Thousand - - 9.51 Million
Total Debt 3.39 Million 4.01 Million 4.95 Million 24 Thousand 1.18 Million 5.5 Million
Net Debt -714 Thousand -33 Thousand -2.97 Million -9.13 Million -7.14 Million -5.95 Million

Balance Sheet Charts